139 related articles for article (PubMed ID: 15300879)
1. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain.
Schwarz A; Gozzi A; Reese T; Bertani S; Crestan V; Hagan J; Heidbreder C; Bifone A
Synapse; 2004 Oct; 54(1):1-10. PubMed ID: 15300879
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
Reavill C; Taylor SG; Wood MD; Ashmeade T; Austin NE; Avenell KY; Boyfield I; Branch CL; Cilia J; Coldwell MC; Hadley MS; Hunter AJ; Jeffrey P; Jewitt F; Johnson CN; Jones DN; Medhurst AD; Middlemiss DN; Nash DJ; Riley GJ; Routledge C; Stemp G; Thewlis KM; Trail B; Vong AK; Hagan JJ
J Pharmacol Exp Ther; 2000 Sep; 294(3):1154-65. PubMed ID: 10945872
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A.
Schwarz AJ; Gozzi A; Reese T; Heidbreder CA; Bifone A
Magn Reson Imaging; 2007 Jul; 25(6):811-20. PubMed ID: 17442525
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
[TBL] [Abstract][Full Text] [Related]
5. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI.
Chen YI; Choi JK; Jenkins BG
Synapse; 2005 Feb; 55(2):80-8. PubMed ID: 15529335
[TBL] [Abstract][Full Text] [Related]
6. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.
Chen YC; Choi JK; Andersen SL; Rosen BR; Jenkins BG
Psychopharmacology (Berl); 2005 Aug; 180(4):705-15. PubMed ID: 15536545
[TBL] [Abstract][Full Text] [Related]
7. Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain.
Southam E; Lloyd A; Jennings CA; Cluderay JE; Cilia J; Gartlon JE; Jones DN
Brain Res; 2007 May; 1149():50-7. PubMed ID: 17382304
[TBL] [Abstract][Full Text] [Related]
8. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging.
Ireland MD; Lowe AS; Reavill C; James MF; Leslie RA; Williams SC
Neuroscience; 2005; 133(1):315-26. PubMed ID: 15893653
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine decreases behavioral inhibition by stimulation of dopamine D2, but not D3, receptors.
van Gaalen MM; Unger L; Jongen-Rêlo AL; Schoemaker H; Gross G
Behav Pharmacol; 2009 Sep; 20(5-6):484-91. PubMed ID: 19696659
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
Gál K; Gyertyán I
Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
[TBL] [Abstract][Full Text] [Related]
11. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A
J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787
[TBL] [Abstract][Full Text] [Related]
12. SB-277011 GlaxoSmithKline.
Remington G; Kapur S
Curr Opin Investig Drugs; 2001 Jul; 2(7):946-9. PubMed ID: 11757796
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine lowers brain stimulation reward (BSR) threshold in alcohol-preferring (P) and -nonpreferring (NP) rats: regulation by D-sub-1 and D-sub-2 receptors in the nucleus accumbens.
Eiler WJ; Masters J; McKay PF; Hardy L; Goergen J; Mensah-Zoe B; Seyoum R; Cook J; Johnson N; Neal-Beliveau B; June HL
Exp Clin Psychopharmacol; 2006 Aug; 14(3):361-76. PubMed ID: 16893279
[TBL] [Abstract][Full Text] [Related]
14. Strain differences in the distribution of dopamine (DA-2 and DA-3) receptor sites in rat brain.
Yaroslavsky I; Colletti M; Jiao X; Tejani-Butt S
Life Sci; 2006 Jul; 79(8):772-6. PubMed ID: 16574158
[TBL] [Abstract][Full Text] [Related]
15. The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats.
Thanos PK; Katana JM; Ashby CR; Michaelides M; Gardner EL; Heidbreder CA; Volkow ND
Pharmacol Biochem Behav; 2005 May; 81(1):190-7. PubMed ID: 15894078
[TBL] [Abstract][Full Text] [Related]
16. Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists.
Loiseau F; Millan MJ
Eur Neuropsychopharmacol; 2009 Jan; 19(1):23-33. PubMed ID: 18793829
[TBL] [Abstract][Full Text] [Related]
17. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI.
Dixon AL; Prior M; Morris PM; Shah YB; Joseph MH; Young AM
Neuropharmacology; 2005 Feb; 48(2):236-45. PubMed ID: 15695162
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
19. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
20. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration.
Schwarz AJ; Zocchi A; Reese T; Gozzi A; Garzotti M; Varnier G; Curcuruto O; Sartori I; Girlanda E; Biscaro B; Crestan V; Bertani S; Heidbreder C; Bifone A
Neuroimage; 2004 Sep; 23(1):296-304. PubMed ID: 15325377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
